The molecular diagnosis of NHL is proceeded by a combination of several biological markers including cell surface markers, such as CD3 for T cells, CD20 for B cells, CD56 for NK cells, and Ki-67 index which indicates the proliferation of tumor cells. This evidence concerns the gene MKI67 and non-Hodgkin lymphoma.